These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 4657915)
21. [Hepatic coma. Treatment with L-dopa. Preliminary report]. Hernández Peniche J; González Posada JC; Tirado Arroyave S Prensa Med Mex; 1972; 37(5):161-2. PubMed ID: 5069454 [No Abstract] [Full Text] [Related]
22. Mental complications of L-dopa therapy in Parkinson's patients. Ginath Y; Lavy S; Abramsky O; Carmon A Isr Ann Psychiatr Relat Discip; 1971 Dec; 9(3):252-64. PubMed ID: 5291459 [No Abstract] [Full Text] [Related]
23. [Psychiatric complications of L-Dopa treatment of parkinsonism]. Refsum H Tidsskr Nor Laegeforen; 1973 Apr; 93(10):680-5. PubMed ID: 4755082 [No Abstract] [Full Text] [Related]
24. [Results of treatment of Parkinsonism with L-dopa]. De Divitiis E; D'Andrea F; Signorelli CD Sist Nerv; 1970; 22(2):99-108. PubMed ID: 5504563 [No Abstract] [Full Text] [Related]
25. [Two years experience with L-DOPA in association with a decarboxylase inhibitor]. Siegfried J Rev Neurol (Paris); 1970 Apr; 122(4):243-8. PubMed ID: 5472041 [No Abstract] [Full Text] [Related]
26. Failures of L-dopa. Paulson GW Ohio State Med J; 1973 Dec; 69(12):896-8. PubMed ID: 4769406 [No Abstract] [Full Text] [Related]
27. [L-dopa treatment and vitamin B 6 --clinical and chemical studies]. Mawatari S; Izumi K; Kuroiwa Y Rinsho Shinkeigaku; 1972 Feb; 12(2):105-9. PubMed ID: 4674755 [No Abstract] [Full Text] [Related]
28. Abnormal mouth-movements and oral damage associated with L-DOPA treatment. Sacks OW; Ross SJ; DePaola DP; Kohl MS Ann Dent; 1970; 29(4):130-44. PubMed ID: 5275661 [No Abstract] [Full Text] [Related]
30. [Preliminary impressions of the therapeutic effectiveness of L-dopa in Parkinson's disease]. Buscaino GA; Campanella G Sist Nerv; 1970; 22(2):82-91. PubMed ID: 5504561 [No Abstract] [Full Text] [Related]
31. Metabolism and clinical assessment of L-dopa in parkinsonism. Ericsson AD; McCann D; Sharpless N; Reveno W Neurology; 1970 Apr; 20(4):402. PubMed ID: 4935027 [No Abstract] [Full Text] [Related]
32. [Use of L-DOPA in the therapy of parkinsonism]. D'Andrea F; De Divitiis E; Signorelli CD; Cerillo A; Tedeschi G Rass Int Clin Ter; 1971 Feb; 51(4):193-221. PubMed ID: 4930734 [No Abstract] [Full Text] [Related]
34. The effects of L-dopa therapy in Parkinson's disease. Thompson RA; White JC; Echols CL Ariz Med; 1970 Jul; 27(7):5-10. PubMed ID: 5432717 [No Abstract] [Full Text] [Related]
35. [L-dopa treatment of persons with parkinsonism in a hospital for geriatric rehabilitation]. Antonini F; Baroni A; Roveyaz L Sist Nerv; 1970; 22(2):74-81. PubMed ID: 5504560 [No Abstract] [Full Text] [Related]
36. [L-Dopa therapy in Parkinson's disease. A double-blind study]. Worm-Petersen J; Dupont E; Mikkelsen B Ugeskr Laeger; 1971 Nov; 133(47):2321-6. PubMed ID: 4944651 [No Abstract] [Full Text] [Related]
37. [Fatal viral hepatitis during treatment with L-dopa]. Caron JC; Dequiedt P; Warot P Lille Med; 1971 Oct; 16(8):1071-3. PubMed ID: 5120774 [No Abstract] [Full Text] [Related]
38. [Effects of L-dopa or amantadine treatment on the spindles of sleep in Parkinson's syndromes]. Puca FM; Bricolo A; Turella G Rev Neurol (Paris); 1972 Aug; 127(2):313. PubMed ID: 4666639 [No Abstract] [Full Text] [Related]
39. [Clinical experience with L-DOPA in the treatment of parkinsonism]. Chiba T No To Shinkei; 1970 Dec; 22(12):1399-405. PubMed ID: 5536833 [No Abstract] [Full Text] [Related]